TRIM2 and neoplasm: In both TNBC and ER-negative tumours, high TRIM2 protein retained its predictive power for BCSS, DFS, and DMFS, remaining independent of established prognostic factors, namely, tumour size, tumour grade, and lymph node stage (p < 0.05, Table 3 and Supplementary Table S3).